Free press releases distribution network?

Agency / Source: Becton, Dickinson and Company

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow - BD FACSVerse™ Flow Cytometer and BD FACSuite™ Software provide upgrade path up to 10 parameters
BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow

 

PRZOOM - /newswire/ - San Jose, CA, United States, 2011/05/20 - BD FACSVerse™ Flow Cytometer and BD FACSuite™ Software provide upgrade path up to 10 parameters. NYSE: BDX

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

BD Biosciences, a segment of BD (Becton, Dickinson and Company), launched today the BD FACSVerse™ Flow Cytometer, a flexible, reliable and scalable system that can analyze up to 10 parameters and support a wide range of research applications.

“We engineered cutting-edge innovation into the BD FACSVerse System from the ground up, with three foundations in mind,” said James Glasscock, President of Cell Analysis, BD Biosciences. “First, we wanted to provide researchers with a single system that could handle routine applications along with complex multi-color experiments with precision and reproducibility. Second, we sought to streamline workflow and make the system easy to use with built-in intelligence. Lastly, we wanted to help protect our customers’ investment by giving them an upgrade path from 6 parameters up to 10 parameters as well as multiple optional capabilities that will allow them to meet the future demands of their research.”

With the new BD FACSuite™ Software System for the BD FACSVerse Flow Cytometer, users can now automate routine tasks, such as instrument startup, setup, sample acquisition, and data analysis, and complete others with minimal clicks The software package’s modular architecture enables users to multitask, performing data analysis while the system is acquiring data. According to Glasscock, the software introduces a powerful new paradigm that eliminates the need for daily spill over correction, which is essential for today’s multicolor analysis. BD FACSuite Software enables assays and experiments to be exported to other BD FACSVerse Systems around the globe, minimizing commonly encountered system and user-related variances.

The BD FACSVerse Flow Cytometer has built-in intelligence that is intended to reduce errors, increase efficiency, automate processes and minimize user interaction. Some examples include:

• Vacuum-based fluidic subsystem that allows exceptional flexibility in sample introduction;
• New setup and QC concepts that eliminate the need for daily compensation for standard fluorochromes; and
• Intelligence and innovation that are built into components across the system that streamline many operations and prevent errors.

To support a wide range of applications, the system provides optional predefined BD research assays for apoptosis, cell cycle, cell proliferation, and cytokine detection, which are matched with BD reagent kits for reproducible results. The system also facilitates the development of user-defined experiments. Researchers can convert their experiments to reusable assays that include relevant settings, acquisition and analysis worksheets, and gating strategies. They can also establish report parameters to reduce data variability between users and laboratories for the same application.

The BD FACSVerse Flow Cytometer is available in 4-color, 6-color and 8-color configurations with forward-scatter and side-scatter support for up to 10 total parameters. The 4- and 6-color systems can be expanded with a field upgrade. The system has a compact footprint that enables it to fit easily on standard laboratory bench tops.

For more information on the BD FACSVerse Flow Cytometer, please visit bdbiosciences.com/go/verse.

About BD
BD (bd.com) is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Becton, Dickinson and Company

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


BD Biosciences Launches New Cell Analyzer to Streamline Research Workflow

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
BD |
Contact: Jeff Ezell - BD.com 
201-847-5533 jeff_ezell[.]bd.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Becton, Dickinson and Company securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Becton, Dickinson and Company / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today